Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas
- 14 October 2004
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1690 (2) , 110-117
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cellsAnnals of Oncology, 2004
- Reduced folate carrier protein expression in osteosarcomaCancer, 2003
- CARRIER-MEDIATED MEMBRANE TRANSPORT OF FOLATES IN MAMMALIAN CELLSAnnual Review of Nutrition, 1999
- Topological and Functional Analysis of the Human Reduced Folate Carrier by Hemagglutinin Epitope InsertionJournal of Biological Chemistry, 1999
- Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.Journal of Clinical Oncology, 1998
- Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1998
- OSTEOSARCOMAPediatric Clinics of North America, 1997
- Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.Journal of Clinical Oncology, 1992
- Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.Journal of Clinical Oncology, 1991
- Transport of methotrexate in chinese hamster ovary cells: A mutant defective in methotrexate uptake and cell bindingArchives of Biochemistry and Biophysics, 1983